Transgenic Mouse Models of BCR/ABL-Positive Chronic Myelogenous Leukemia: A Review

Publisher： Bentham Science Publishers

E-ISSN： 1875-5488|6|2|89-95

ISSN： 1389-2029

Source： Current Genomics, Vol.6, Iss.2, 2005-03, pp. : 89-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bcr-Abl and inhibition of apoptosis in chronic myelogenous leukemia cells

By Fernandez-Luna J.L.  

Apoptosis, Vol. 5, Iss. 4, 2000-10 ,pp. : 315-318

Springer Publishing Company

Access to resources Recommend Favorite

Chromatin nucleoprotein complexes containing tightly bound c-abl, p53 and bcl-2 gene sequences: correlation with progression of chronic myelogenous leukemia

By Nicolson N.L.   Talpaz M.   Nicolson G.L.  

Gene, Vol. 169, Iss. 2, 1996-03 ,pp. : 173-178

Elsevier

Access to resources Recommend Favorite

Modeling Imatinib-Treated Chronic Myelogenous Leukemia: Reducing the Complexity of Agent-Based Models

By Kim Peter  

Bulletin of Mathematical Biology, Vol. 70, Iss. 3, 2008-04 ,pp. : 728-744

Springer Publishing Company

Access to resources Recommend Favorite

Transgenic mouse models of Alzheimer's disease

By Hock B.J.   Lamb B.T.  

Trends in Genetics, Vol. 17, Iss. 10, 2001-10 ,pp. : 7-12

Elsevier

Access to resources Recommend Favorite

Differential Regulation of Vitamin D Receptors in Clonal Populations of a Chronic Myelogenous Leukemia Cell Line

By Iwata K.   Kouttab N.   Ogata H.   Morgan J.W.   Maizel A.L.   Lasky S.R.  

Experimental Cell Research, Vol. 225, Iss. 1, 1996-05 ,pp. : 143-150

Elsevier

Access to resources Recommend Favorite